# A Pilot Trial of Ranolazine to Treat Patients With Dilated Cardiomyopathy

> **NCT02133911** · PHASE2 · COMPLETED · sponsor: **University Medical Centre Ljubljana** · enrollment: 10 (actual)

## Conditions studied

- Dilated Cardiomyopathy

## Interventions

- **DRUG:** Ranolazine

## Key facts

- **NCT ID:** NCT02133911
- **Lead sponsor:** University Medical Centre Ljubljana
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-05-01
- **Primary completion:** 2015-12-15
- **Final completion:** 2016-04-02
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2021-04-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02133911

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02133911, "A Pilot Trial of Ranolazine to Treat Patients With Dilated Cardiomyopathy". Retrieved via AI Analytics 2026-07-02 from https://api.ai-analytics.org/clinical/NCT02133911. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*